BeyondSpring Inc.

Healthcare · Biotechnology · United States

Last price 0.5167 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 21.25M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

BeyondSpring Inc., a clinical stage biopharmaceutical company, focuses on developing and selling clinical-stage biopharmaceutical therapies focused on oncology and immunology. The company operates through two segments: the Plinabulin pipeline and the TPD platform. The company’s lead asset is Plinabulin, a selective immunomodulating microtubule-binding agent that has completed Phase III clinical trials for treatment of non-small cell lung cancer (NSCLC); and as an anti-cancer agent, as well as for the prevention of chemotherapy-induced neutropen...